WASJ World Academy of Sciences Journal 2632-2900 2632-2919 D.A. Spandidos WASJ-6-6-00288 10.3892/wasj.2024.288 Articles Association between TSH and creatinine levels in patients with hypothyroidism HwisaSara A. 1 SolimanNamat A. 1 FarajMofeda M. 2 SalemGhada M. 3 AlostaAnaya M. 4 AlshoshanSalsabiel O. 4 AlfituriRetag F. 4 AziezZaid A. 4 Department of Medical and Basic Sciences, Faculty of Dentistry, University of Zawia, Zawia 16418, Libya Department of Medical Technology, Faculty of Health Sciences University of Zawia, Zawia 16418, Libya Libyan Authority for Scientific Research, Tripoli 80045, Libya Department of Medical Technology, Higher Institute of Medical Sciences and Technologies, Tripoli 16418, Libya Correspondence to: Dr Sara A. Hwisa, Department of Medical and Basic Sciences, Faculty of Dentistry, University of Zawia, Jamal Abdel-Nasser Street, Zawia 16418, Libya sara.ab.mu.hw@gmail.com Nov-Dec 2024 10 10 2024 6 6 73 20 06 2024 11 09 2024 Copyright: © 2024 Hwisa et al. 2024 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Thyroid hormones play a crucial role in regulating renal function, and hypothyroidism ranks among the most prevalent endocrine disorders worldwide. The present study aimed to investigate the association between thyroid stimulating hormone (TSH) levels and creatinine levels in patients with hypothyroidism. A descriptive cross-sectional study design was applied, and a cohort of patients with hypothyroidism was recruited from medical centers. The age range of the participants was between 13 to 84 years. The patients were categorized into four groups based on their TSH values as follows: Group 1, patients with a TSH level >4.00 µIU/l; group 2, patients with a TSH level <0.46 µIU/l; group 3, patients with a TSH level ranging from 0.60 to 2.8 µIU/l; and group 4, patients with a TSH level ranging from 2.94 to 3.60 µIU/l. Among the 120 participants, consisting of 30 control subjects and 90 patients with hypothyroidism, 74 subjects not undergoing dialysis exhibited statistically significant differences in TSH and creatinine levels across the four hypothyroid groups (P<0.05). Correlation analysis revealed positive correlations between TSH and creatinine levels in groups 1 (r=0.446, P=0.043), 3 (r=0.541, P=0.001) and 4 (r=0.748, P=0.005). Conversely, a negative correlation was observed between TSH and creatinine levels in group 2 (r=-0.892, P=0.001). The control group displayed a weak negative correlation between TSH and creatinine (r=-0.367, P=0.046). The TSH levels exhibited positive correlations with creatinine levels in all groups, with the exception of group 2, where a negative correlation was observed. These findings suggest a potential association between thyroid function and kidney dysfunction. This observation highlights a complex interaction between thyroid function and kidney health. The positive correlation between TSH and creatinine levels in the majority of the groups suggests that higher TSH levels are associated with higher creatinine levels, indicating potential thyroid dysfunction and impaired kidney function. However, the negative correlation in group 2 suggests a different or even opposite relationship in that specific group.

 thyroid stimulating hormone hypothyroidism creatinine renal function thyroid function kidney dysfunction Funding: No funding was received. Introduction

Thyroid-stimulating hormone (TSH), produced by the anterior pituitary gland, plays a crucial role in regulating the thyroid hormones generated by the thyroid gland (1). On the other hand, creatinine is a waste product generated during muscle metabolism (2) and serves as a commonly used indicator of kidney function (3,4).

Hypothyroidism is often accompanied by a decrease in the glomerular filtration rate, resulting in the reduced clearance of creatinine from the bloodstream (5). This leads to significantly higher levels of creatinine due to decreased renal filtration and increased production from muscle breakdown.

Thyroid dysfunction, whether in the form of subclinical or overt thyroid disease, is recognized as a risk factor for chronic kidney disease due to its association with significant alterations in creatinine levels (6). Several studies have consistently demonstrated an association between serum TSH levels, the risk of developing hypothyroidism and renal function (7-9). TSH exerts a direct influence on the thyroid gland and has been found to affect kidney function, particularly concerning the creatinine levels. Studies have established an association between TSH and glycated albumin (10), as well as between TSH and serum creatinine levels (11), particularly among individuals diagnosed with hypothyroidism. In individuals with overt hypothyroidism and TSH levels ≥10.0 µIU/l, there is a marked increase in the serum levels of urea, creatinine and uric acid. Similarly, patients with subclinical hypothyroidism exhibit significantly higher serum levels of urea and creatinine (12). TSH demonstrates a significant association with serum creatinine levels in both overt and subclinical hypothyroidism cases (13).

Although there are a limited number of studies available on the impact of hypothyroidism on renal function, particularly as regards creatinine, a reversible elevation of serum creatinine has been observed following hormone substitution therapy in patients with hypothyroidism (14-17).

The aim of the present study was to examine and evaluate the association between serum TSH levels and alterations in the biochemical markers of renal function, specifically creatinine levels, among patients with hypothyroidism.

 Patients and methods <sec> <title>Study design

The present study was a descriptive cross-sectional study conducted among a convenience sample of volunteers located in Tripoli, Libya.

 Study setting

The present study was carried out by distributing questionnaires through personal interviews to facilitate completion by the patients. The cases were randomly selected from subjects attending the following outpatient clinics: Tripoli University Hospital, the Tripoli Center for Kidney Services, Al-Firdous Clinic in Tripoli, and Yashfin Specialized Clinic (all in Tripoli, Libya).

 Ethical considerations

Ethical approval for conducting the study was obtained from the Higher Institute of Medical Sciences and Technology, Tripoli, Libya. Informed consent was obtained from individuals or legal guardians through an official document after submitting the study proposal, ensuring that participation was voluntary. Volunteers were also informed that their responses would be anonymous and confidential.

 Sample size

The number of volunteers participating in the study was 120, representing the total number of individuals enrolled from November 7, 2022 to January 18, 2023.

 Criteria of study groups

Patients with hypothyroidism, in the age group of 13-84 years of both sexes were included.

 Study groups

The patients with hypothyroidism with biochemical measurements were divided into four groups according to their serum TSH level, as follows: Group 1, patients with a TSH level >4.00 µIU/l; group 2, patients with a TSH level <0.46 µIU/l; group 3, patients with a TSH level ranging from 0.60 to 2.8 µIU/l; and group 4, patients with a TSH level ranging from 2.94 to 3.60 µIU/l. The cases comprising the control group were randomly selected, and they did not have thyroid disorders or kidney disorders. The control group consisted of 30 participants who had normal levels of blood TSH (0.4-4.0 µIU/l) and creatinine (0.6-1.4 mg/dl).

 Statistical analysis

Statistical analysis was conducted using IBM SPSS version 21 software (IBM Corp.). Descriptive procedures, including frequency, percentages, mean, and standard deviation (SD), were employed. Statistical tests such as the independent samples (unpaired) Student's t-test, and one-way ANOVA with Tukey's HSD post hoc test were utilized. Pearson's correlation coefficient was applied to examine the correlation between serum creatinine levels and the severity of hypothyroidism. A P-value <0.05 was considered to indicate a statistically significant difference, while a P-value <0.001 was considered to indicate a highly statistically significant difference.

 Results <sec> <title>Selection of patients with hypothyroidism for analysis

Among the 90 patients diagnosed with hypothyroidism in the medical clinic, 74 patients were included in the biochemical parameters of the present study. These patients had serum TSH levels ranging from <0.4 to >4.0 µIU/l and serum creatinine levels from 0.6 to >1.4 mg/dl. The remaining 16 patients were undergoing hemodialysis and were excluded from the study.

 Patient demographics

The present study found that, among the 74 participating patients with hypothyroidism, 28 patients were male and 46 patients were female. The male patients had a mean age of 46 years, while the female patients had a slightly older mean age of 49 years, indicating that hypothyroidism affects different age groups similarly across the sexes. There was no statistically significant difference in age between the two sex groups (P=0.322), indicating that hypothyroidism affects different age groups similarly across sexes (Table I).

The mean TSH levels for the males were recorded at 3 µIU/l, while the females had a mean TSH level of 2 µIU/l. No significant difference in TSH levels were observed between the sexes (P=0.566), suggesting that the severity of hypothyroidism, as measured using the TSH levels, was comparable across both sexes (Table I).

The male patients had a mean creatinine level of 0.67 mg/dl, while the female patients exhibited a higher mean level of 1.05 mg/dl. Again, there was no significant difference in creatinine levels between the sexes (P=0.249; Table I). This could point to a slight trend of higher kidney function markers in males. As shown in Table I, the findings indicated a slight increase in the mean TSH levels in males compared with females, while the creatinine levels were higher on average in the female than in the male patients.

 Age of the participants with hypothyroidism

The study population, comprising individuals with hypothyroidism, was categorized into seven distinct age groups as follows: ≤20 years, 21-30 years, 31-40 years, 41-50 years, 51-60 years, 61-70 years and ≥71 years. Notably, the age group of 41 to 50 years exhibited a prominent presence among the collected samples. Furthermore, the mean age for the female participants was determined to be 49 years, while for the male participants, it was 46 years (Table I).

 Biochemical parameters among the hypothyroidism groups and control group

The investigation revealed that group 1, consisting of individuals with TSH levels >4.0 µIU/l, demonstrated a lower mean creatinine value of 0.65 mg/dl compared with the control group (0.77 mg/dl). Conversely, group 2, comprising individuals with TSH levels <0.46 µIU/l, exhibited a notably higher mean creatinine value of 2.50 mg/dl. Group 3, representing individuals with TSH levels ranging from 0.47 to 2.8 µIU/l, displayed a mean creatinine value of 0.70 mg/dl, which was similar to that of the control group. Similarly, group 4, including individuals with TSH levels ranging from 2.94 to 3.6 µIU/l, exhibited a mean creatinine value of 0.75 mg/dl, which was close to that of the control group (Table II).

 Correlation of the serum TSH and creatinine levels in the various groups

The present study examined the correlation between creatinine levels and TSH in individuals with hypothyroidism. The results presented in Table III provide comprehensive correlation coefficients (r) and corresponding P-values, illustrating the correlation between TSH and creatinine across the different groups. A rigorous Pearson's correlation analysis was performed to investigate the correlation between serum TSH and serum creatinine levels. The findings consistently revealed a statistically significant correlation (P<0.05) between these parameters in all groups, as described below:

Correlation between serum TSH and creatinine levels in the control group. In the present study, a negative correlation was observed between the serum TSH and creatinine levels in the control group, which included 30 participants without hypothyroidism (r=-0.367, P=0.046) (Table III).

Correlation between serum TSH and creatinine levels in patients with hypothyroidism in group 1. Group 1 consisted of 21 cases of hypothyroidism, including 12 females and 9 males, with TSH levels >4.0 µIU/l. Notably, the results revealed a positive correlation between the serum TSH and creatinine levels in this group (r=0.446, P=0.043) (Table III).

Correlation between serum TSH and creatinine levels in patients with hypothyroidism in group 2. The second group consisted of 9 cases of hypothyroidism, comprising 8 females and 1 male, with TSH levels <0.46 µIU/l. The analysis of creatinine levels in this patient cohort revealed a wide range, from 0.30 to 9.50 mg/dl. Of note, a significant negative correlation was observed between TSH levels and creatinine in this group (r=-0.892, P=0.001) (Table III).

Correlation between serum TSH and creatinine levels in patients with hypothyroidism in group 3. In group 3, which comprised 32 hypothyroidism patients (17 females and 15 males) with TSH levels ranging from 0.47 to 2.8 µIU/l and who were not undergoing hemodialysis, the analysis of creatinine levels revealed a range from 0.10 to 1.50 mg/dl. Of note, a positive correlation was observed between the TSH and creatinine levels, with a correlation coefficient of 0.541 (P=0.001) (Table III).

Correlation between serum TSH and creatinine levels in patients with hypothyroidism in group 4. In group 4, which included 12 individuals diagnosed with hypothyroidism (8 females and 4 males), TSH levels ranged from 2.94 to 3.78 µIU/l. The assessment of creatinine levels in this group revealed values spanning from 0.40 to 1.00 mg/dl. Notably, a significant positive correlation was observed between serum TSH levels and creatinine in this group (r=0.748, P=0.005) (Table III).

 Discussion

The present study investigated the association between TSH levels and kidney function parameters in individuals with hypothyroidism and those without hypothyroidism or kidney disease. In terms of TSH levels, males exhibited higher mean values (3.10 µIU/l) compared to females (2.81 µIU/l), though this difference was not statistically significant. This finding is consistent with previous studies that reported higher mean TSH levels in males with hypothyroidism compared to females (18,19). Conversely, mean creatinine levels were lower in males (0.67 mg/dl) compared to females (1.05 mg/dl).

The prevalence of hypothyroidism in the present study was higher in females (62.16%) compared with males (37.84%), resulting in a male-to-female ratio of 1:1.64 as presented in Table IA. This ratio is lower than the previously reported ratio of 1:4.68(18).

The mean age of all the patients diagnosed with hypothyroidism in the present study was 48.05±12.62 years, closely aligning with the previously reported average age of 47±14.48 years (19). The highest incidence of hypothyroidism was observed in the age group of 41-50 years (37.84%), followed by the 51-60 years group (27.03%). By contrast, the <20 and 21-30 years age groups accounted for a smaller proportion of patients, of 1.35 and 4.05%, respectively. An alternate study reported a higher prevalence of hypothyroidism among individuals aged 21-30 (33.53%) and the 31-40 age group (24.96%) (18).

Several studies have explored the association between the serum TSH and creatinine levels in individuals with hypothyroidism (9,14,20-22). Table II presents the mean creatinine values in both the patients with hypothyroidism and the controls, highlighting the potential impact of hypothyroidism on renal function. The present study demonstrated a significant increase in mean serum creatinine levels in the patients with hypothyroidism in group 2 compared with the other groups. A statistically significant association between TSH and creatinine levels was observed (P<0.05), which is consistent with the findings from other studies (23-26).

In group 1, the lower mean creatinine levels with higher mean TSH levels suggest a potential association between severe hypothyroidism and decreased creatinine levels. By contrast, group 2, with significantly lower mean TSH levels and significantly higher mean creatinine levels, may indicate a potential kidney disorder. In group 3, where the TSH levels were within the normal range, no significant effect on creatinine levels was observed. For group 4, mild elevations were observed in mean TSH levels that may not substantially affect the mean creatinine levels. These findings are consistent with previous research (11,14,15,24,27-29).

Correlation analysis revealed that in the control group, increasing TSH levels within the normal range were associated with a decrease in creatinine levels. In Group 1, a positive correlation between TSH and creatinine levels was observed, indicating that higher TSH levels in cases of severe hypothyroidism are associated with elevated creatinine levels. This is consistent with previous studies (12,13,23,26).

Conversely, group 2 exhibited a strong negative correlation between TSH and creatinine levels, suggesting that lower TSH levels are linked to higher creatinine levels, indicating potential renal dysfunction, in accordance with previous studies (30,31). In group 3, a positive correlation between TSH and creatinine levels was observed, suggesting that TSH levels within the normal range may be associated with increased creatinine levels, in accordance with previous findings (32). Group 4 also demonstrated a positive correlation between TSH and creatinine levels, in accordance with previous findings (33), indicating that even slight elevations in TSH levels may be related to creatinine levels.

The present study highlights the significant impact of hypothyroidism on creatinine levels compared to healthy controls. These findings are consistent with those of previous studies that have reported significantly elevated serum creatinine levels in patients with hypothyroidism, indicating possible renal impairment (30-34). Previous research has also reported significantly elevated serum creatinine levels in cases with subclinical hypothyroidism, emphasizing its potential as an early biomarker for detecting hypothyroidism (25). Furthermore, another study reported a substantial increase in serum creatinine levels in patients with hypothyroidism, along with alterations in thyroid hormone levels and other renal function parameters (35). Additionally, a previous study confirmed elevated serum creatinine levels in cases with both subclinical and overt hypothyroidism, further supporting the association between hypothyroidism and increased creatinine levels (36).

The present study has several limitations, which should be mentioned. These include a small sample size, an imbalanced sex distribution among participants, and limited representation from both public and private hospitals. Additionally, the lack of family physician visits presented a significant challenge in evaluating creatinine levels among hypothyroid patients. Despite these limitations, the outcomes of the present were considered satisfactory for achieving the research objectives.

In conclusion, the present cross-sectional study examined and analyzed the serum levels of TSH and creatinine in various groups of individuals with hypothyroidism. By evaluating these biomarkers, the study identified significant associations and differences related to hypothyroidism, contributing valuable insight into the interplay between TSH and creatinine levels within the study population.

Based on the findings of the present study, it is crucial to provide appropriate treatment strategies for patients with hypothyroidism, recognizing it as a risk factor for the development of renal failure, in order to achieve optimal treatment outcomes. Understanding this association can lead to the avoidance of unnecessary investigations, the reduction of treatment costs, and the alleviation of the anxiety of patients, particularly when creatinine levels are elevated in the presence of hypothyroidism.

On the whole, although the present study had certain limitations due to its small sample size, it underscores the need for further research with a larger number of participants to yield more reliable results. Additionally, it is important to note that the findings presented herein were exploratory and specific to the Tripoli region in Libya. Therefore, conducting a comprehensive survey across Libya is necessary to gain a more thorough understanding. Support from the Libyan Authority for Scientific Research for further research in this field would be required, and additional studies are required to explore the mechanisms through which various biochemical parameters relate to thyroid dysfunction. Health officials need to allocate funds for diagnosis and invest in public education on the importance of early detection and treatment of hypothyroidism. This approach could lead to improved strategies for maintaining renal function. Creatinine levels in patients with hypothyroidism should be closely monitored, and any changes should be discussed with their healthcare provider. Thus, the present study serves as a valuable resource for doctors, highlighting the importance of evaluating renal function in each patient with hypothyroidism to identify potential issues early and implement appropriate safeguard measures.

 Acknowledgements

Not applicable.

 Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

 Authors' contributions

All authors (SAH, NAS, MMF, GMS, AMA, SOA, RFA and ZAA) made significant contributions to the acquisition, analysis and interpretation of the data. SAH and SOA collected samples from the center for analysis and presented accurate research results. All authors have reviewed, and have read and approved the final version of the manuscript. SAH and SOA confirm the authenticity of all the raw data.

 Ethics approval and consent to participate

Ethical approval for conducting the study was obtained from the Higher Institute of Medical Sciences and Technology, Tripoli, Libya. Informed consent was obtained from individuals or legal guardians through an official document after submitting the study proposal, ensuring that participation was voluntary. Volunteers were also informed that their responses would be anonymous and confidential.

 Patient consent for publication

Not applicable.

 Competing interests

The authors declare that they have no competing interests.

 References ChakerLPeetersRPThyroid-stimulating hormone. In The Pituitary. Academic Press, pp173-207, 2022. FeherJJQuantitative human physiology: An introduction. Academic press, 2017. LermaEVSparksMATopfJNephrology secrets E-book. Elsevier Health Sciences, 2018. LarsenTSeeEJHolmesNEBellomoREstimating baseline creatinine to detect acute kidney injury in patients with chronic kidney diseaseNephrology2843444520233727789810.1111/nep.14191 YangBZhouWCuiLTianLNiYYangMYangYThe predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathyFront Endocrinol (Lausanne)15137282420243880810910.3389/fendo.2024.1372824 SimeoniMCerantonioAPastoreILiguoriRGrecoMFotiDGullettaEBrunettiAFuianoGThe correct renal function evaluation in patients with thyroid dysfunctionJ Endocrinol Invest3949550720162651199910.1007/s40618-015-0402-8 LiuZXLvJLXiangYLDengWHuangHSunYHLiLHThe association between thyroid hormones and renal function in euthyroid Chinese individuals: A Population-Based Cross-Sectional studyCureus16e5568220243858671310.7759/cureus.55682 RheeCMKalantar-ZadehKStrejaECarreroJJMaJZLuJLKovesdyCPThe relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney diseaseNephrol Dial Transplant3028228720152524633510.1093/ndt/gfu303 HuMAsamiCIwakuraHNakajimaYSemaRKikuchiTMiyataTSakamakiKKudoTYamadaMDevelopment and preliminary validation of a machine learning system for thyroid dysfunction diagnosis based on routine laboratory testsCommun Med (Lond)2920223560327710.1038/s43856-022-00071-1 KondaveetiSBShakerIAEstimation of glycated albumin levels in various thyroid disordersInt J Cur Res Rev61382014 NaguibRElkemaryEThyroid dysfunction and renal function: A crucial relationship to recognizeCureus15e3524220233696891910.7759/cureus.35242 AttaullahSHaqBSAhmedZCorrelation of thyroid dysfunction with serum creatinineInt J Multidiscip Res Dev288902015 AkagunduzBAkcakayaMEvaluation of the correlation of urea, creatine, and uric acid levels with TSH in patients with newly diagnosed overt and subclinic hypothyroidismEurasian J Med Investigation53173212021 YouASKalantar-ZadehKBrentGANarasakiYDazaASimJJKovesdyCPNguyenDVRheeCMImpact of thyroid status on incident kidney dysfunction and chronic kidney disease progression in a nationally representative cohortMayo Clin Proc99395620243817683310.1016/j.mayocp.2023.08.028 XingYYangLLiuJMaHThe Association with subclinical thyroid dysfunction and uric acidInt J Endocrinol2021972061820213493833410.1155/2021/9720618 YuWWangYMaLGouSFuPAnalysis of thyroid function in ANCA-Associated vasculitis patients with renal injuryJ Pers Med149920243824879910.3390/jpm14010099 JooEYKimYJGoYSongJGRelationship between perioperative thyroid function and acute kidney injury after thyroidectomySci Rep81353920183020197310.1038/s41598-018-31946-w AroraPPrasadSKarunanandBHospital based study of thyroid disorders in rural population of Gurgaon, HaryanaInt J Curr Res Rev862016 GurbuzAFYucelKEffects of hypothyroidism and hyperthyroidism on hematological and biochemical parametersAnn Clin Anal Med14 (Suppl 1)S10S142023 AlsulamiMOAlharbiNMAlsulamiDWAlmaghrabiSJAlbaradeiHAAlhozaliAMAssociation between blood pressure, glomerular filtration rate, and serum thyroid-stimulating hormone levels in hypothyroid patients: A retrospective Single-center studyCureus14e2868620223619965610.7759/cureus.28686 JaiswalNNirwanDSStudy of serum creatinine level in hypothyroidismJ Mahatma Gandhi Univ Med Sci Tech379812018 KaurVSinghKVermaMChanges in biochemical markers of renal function in subclinical and overt hypothyroidismInt J Bioassays4379938022015 PatilVPShilpasreeASPatilVSPravinchandraKRIngleshwarDGVaniACEvaluation of renal function in subclinical hypothyroidismJ Lab Physicians10505520182940320510.4103/JLP.JLP_67_17 MarwahSMehtaMShahHHaridasNTrivediACorrelation of serum uric acid and serum creatinine in hypothyroidismNatl J Physiol Pharm Pharmacol52322352015 ThadaniDKumawatMMahawarSJainAEvaluation of serum creatinine level in subclinical hypothyroidismGJRA1029322021 MahanteshBBShankar PrasadDSSangappaVKSGEvaluation of serum creatinine in subclinical hypothyroidism. A case-control studyInt J Clin Biochemistry Res21821842015 Al FahdiIAl SalmiIAl RahbiFShaheenFHannawiSThyroid dysfunction and kidney dysfunctionOman Med J37e37720223581404110.5001/omj.2022.55 AwadRAMohanDAlalawiFRaileyMAlhadariAAn interesting case of hypothyroidism associated acute kidney injuryIndian J Nephrol3322022420233744889810.4103/ijn.ijn_217_21 TaniHHirashioSTsudaATachiyamaYHaraSMasakiTRenal dysfunction caused by severe hypothyroidism diagnosed by renal biopsy: A case report. CEN Case Rep: February 28, 2024 (Epub ahead of print). JiaDLiangLBTangGHHeHZhangMLiZPLiSQThe association between serum uric acid and creatinine in patients with hypothyroidismSichuan Da Xue Xue Bao Yi Xue Ban46747749201526619549(In Chinese) YosufLMStudy the correlation between thyroid disorder and chronic kidney failureUni Thi-Qar J Sci959652022 KumariBKumarPKeshariJRKumarAPankajSChaudharyRKPSerum BUN and creatinine estimation in patients of overt hypothyroidism: A case control studyInt J Res Med Sci539902017 GhoshMBandyopadhyayKSinhaBKantiMEvaluation of kidney function in hypothyroid subjects and its correlation with FT4 & TSH levelInt J Acad Med Pharm5192819312023 KumarGRPriyadarshiniDVA study on comparison of serum creatinine, serum uric acid and serum zinc levels in hypothyroid and healthy controls-at a tertiary care hospitalInt J Adv Biochem Res318202019 SinghAKKumarRSharmaASharmaDSrivastavaSRenal function derangements in hypothyroidism: A clinical correlation between serum creatinine, urea and uric acid levelsInt J Clin Biochem Res55335362018 ShrivatsavaSA study of serum uric acid levels and serum creatinine levels in hypothyroidismInt J Clin Biochem Res91481532022

Demographic and baseline characteristics of the study participants.

A, Differences in age, TSH and creatinine levels as regards sex
Parameter Sex No. of patients Min Max Mean SD P-valuea
Age (years) of patients Male 28 13.00 84.00 46.18 13.89 0.322
with hypothyroidism Female 46 26.00 76.00 49.20 11.78  
TSH (µIU/l) of patients Male 28 0.39 8.46 3.10 1.93 0.566
with hypothyroidism Female 46 0.02 8.50 2.81 2.19  
Creatinine (mg/dl) of Male 28 0.20 1.20 0.67 0.28 0.249
patients with hypothyroidism Female 46 0.10 9.50 1.05 1.69  
Sex Males: 28 (37.84%) Females: 46 (62.16%)   Ratio: 1:1.64
B, TSH levels as regards sex in each group
  TSH (µIU/l)
Group Sex No. of participants % Min Max Mean SD
CG Male 12 40.00 0.60 3.74 1.99 1.04
  Female 18 60.00 0.45 4.00 1.99 1.17
G1 Male 9 42.90 4.20 8.46 5.35 1.21
  Female 12 57.10 4.25 8.50 5.91 1.23
G2 Male 1 11.10 0.39 0.39 0.39 -
  Female 8 88.90 0.02 0.45 0.27 0.15
G3 Male 15 46.90 0.63 2.85 1.62 0.73
  Female 17 53.10 0.74 2.87 1.77 0.70
G4 Male 4 33.30 3.45 3.78 3.64 0.15
  Female 8 66.70 2.94 3.78 3.24 0.29
C, Creatinine levels as regards sex in each group
  Creatinine (mg/dl)
Group Sex No. of participants % Min Max Mean SD
CG Male 12 40.00 0.54 1.40 0.81 0.21
  Female 18 60.00 0.60 1.00 0.75 0.16
G1 Male 9 42.90 0.20 0.90 0.58 0.24
  Female 12 57.10 0.30 1.10 0.70 0.21
G2 Male 1 11.10 0.40 0.40 0.40 -
  Female 8 88.90 0.30 9.50 2.77 3.73
G3 Male 15 46.90 0.40 1.20 0.70 0.32
  Female 17 53.10 0.10 1.50 0.70 0.33
G4 Male 4 33.30 0.70 0.90 0.85 0.10
  Female 8 66.70 0.40 1.00 0.70 0.20
D, Age demographics of the participants in all groups
Age              
Group ≤20 years 21-30 years 31-40 years 41-50 years 51-60 years 61-70 years ≥71 years
CG 0 (0%) 2 (6.70%) 10 (33.30%) 17 (56.70%) 1 (3.30%) 0 (0%) 0 (0%)
All patients with hypothyroidism 1 (1.35%) 3 (4.05%) 14 (18.92%) 28 (37.84) 20 (27.03) 4 (5.41%) 4 (5.41%)
G1 1 (4.80%) 0 (0%) 6 (28.60%) 9 (42.90%) 4 (19.00%) 1 (4.80%) 0 (0%)
G2 0 (0%) 1 (11.10%) 0 (0%) 1 (11.10%) 6 (66.70%) 0 (0%) 1 (11.10%)
G3 0 (0%) 2 (6.30%) 7 (21.90%) 12 (37.50%) 8 (25.00%) 2 (6.30%) 1 (3.10%)
G4 0 (0%) 0 (0%) 1 (8.30%) 6 (50.00%) 2 (16.70%) 1 2

aComparisons of various parameters among the sex groups with hypothyroidism were performed using an independent samples unpaired Student's t-test to assess differences between the sexes. TSH, thyroid-stimulating hormone, CG, control groups; G1, group 1 (TSH >4.0 µIU/l); G2, group 2 (TSH <0.46 µIU/l); G3, group 3 (TSH 0.47 to 2.8 µIU/l); G4, group 4 (TSH 2.94 to 3.6 µIU/l).

Mean values of different parameters among patients with hypothyroidism and the controls.

Biochemical parameters Group No. of participants Mean SD Comparison vs. group P-value
TSH (µIU/l) CG 30 1.98 1.10 G1 0.001a
          G2 0.001a
          G3 0.7286
          G4 0.001a
  G1 21 5.67 1.22 CG 0.001a
          G2 0.001a
          G3 0.001a
          G4 0.001a
  G2 9 0.28 0.15 CG 0.001a
          G1 0.001a
          G3 0.001a
          G4 0.001a
  G3 32 1.70 0.71 CG 0.7286
          G1 0.001a
          G2 0.001a
          G4 0.001a
  G4 12 3.37 0.31 CG 0.001a
          G1 0.001a
          G2 0.001a
          G3 0.001a
Creatinine (mg/dl) CG 30 0.77 0.18 G1 0.9932
          G2 0.001a
          G3 0.9985
          G4 0.9998
  G1 21 0.65 0.22 CG 0.9932
          G2 0.001a
          G3 0.9998
          G4 0.9985
  G2 9 2.50 3.57 CG 0.001a
          G1 0.001a
          G3 0.001a
          G4 0.002b
  G3 32 0.70 0.32 CG 0.9985
          G1 0.9998
          G2 0.001a
          G4 0.9998
  G4 12 0.75 0.18 CG 0.9998
          G1 0.9985
          G2 0.002b
          G3 0.9998

TSH, thyroid-stimulating hormone. CG: Control Groups, G1: Group 1 (TSH >4.0 µIU/l), G2: Group 2 (TSH <0.46 µIU/l), G3: Group 3 (TSH 0.47 to 2.8 µIU/l), G4: Group 4 (TSH 2.94 to 3.6 µIU/l). Comparisons of the various parameters among the groups were performed using one-way ANOVA (with Tukey's HSD test) (

aP<0.001, indicating a very highly significant difference,

bP<0.01, indicating a highly significant difference).

Correlation of TSH with creatinine levels in all groups.

Groups No. of participants Creatinine (r) P-value
Control groups 30 -0.367 0.046a
Group 1 (TSH > 4.0 µIU/l) 21 0.446 0.043a
Group 2 (TSH < 0.46 µIU/l) 9 -0.892 0.001c
Group 3 (TSH 0.47 to 2.8 µIU/l) 32 0.541 0.001c
Group 4 (TSH 2.94 to 3.7 µIU/l) 12 0.748 0.005b

TSH, thyroid-stimulating hormone.

aIndicates significant correlation (P<0.05);

bindicates highly significant correlation (P<0.01).

cindicates very highly significant correlation (P<0.001).